FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289525568> ?p ?o ?g. }

• W4289525568 endingPage "100370" @default.
• W4289525568 startingPage "100370" @default.
• W4289525568 abstract "Cardioprotective antihyperglycemic agents, SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1RA), improve outcomes of patients with type 2 diabetes, but adoption has been limited. Differences across individuals have been noted but area-level variation is unknown. Given healthcare access and sociodemographic differences, we evaluated whether SGLT2i and GLP-1RA utilization varies across US counties. We linked 2019 Medicare Part D national prescription data with county-level demographic measures from the Agency for Health Quality and Research. We compared the number of beneficiaries receiving prescriptions for any cardioprotective antihyperglycemic to the number receiving metformin prescriptions across US counties. In multivariable linear regression with SGLT2i-to-metformin and GLP1RA-to-metformin prescriptions as outcomes, we evaluated county factors associated with use of cardioprotective agents while adjusting for sociodemographic measures, region, and cardiometabolic risk factor prevalence. In 3066 US counties, there were a median 2,416 (IQR, 1681–3190) metformin-receiving beneficiaries per 100,000 population. A median 6.2% of beneficiaries receiving metformin received SGLT2i therapy, varying across counties (IQR, 3.4%–9.2%). A median 9.4% (IQR, 5.0%–13.0%) of beneficiaries receiving metformin received GLP-1RA. In adjusted analyses, higher percentage of Black population was associated with lower use at the county level of people on SGLT2i or GLP-1RA relative to metformin (a SD higher proportion of Black individuals with 0.4% [95% CI, -0.6% to -0.1%] and 0.5% [-0.8% to -0.2%] lower SGLT2i and GLP-1RA prescribing relative to metformin, respectively; P < 0.01). A higher median age of county residents, rural location, and lower prevalence of diabetes were associated with lower SGLT2i prescribing. Similarly, more advanced age of county residents, rural location, proportion of Hispanic individuals, and household income and lower education levels were associated with lower GLP-1RA prescribing. Prescribing was higher in the Northeast and lower in the West as compared with the Midwest for both classes. There was large variation by county in cardioprotective antihyperglycemic prescribing, with a pattern of lower use in Black-predominant and rural counties, highlighting the critical need to investigate equity in uptake of novel therapeutic agents." @default.
• W4289525568 created "2022-08-03" @default.
• W4289525568 creator A5010423305 @default.
• W4289525568 creator A5017974764 @default.
• W4289525568 creator A5018180754 @default.
• W4289525568 creator A5032296670 @default.
• W4289525568 creator A5064308322 @default.
• W4289525568 creator A5069135092 @default.
• W4289525568 creator A5088028306 @default.
• W4289525568 date "2022-09-01" @default.
• W4289525568 modified "2023-10-06" @default.
• W4289525568 title "County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries" @default.
• W4289525568 cites W1581995601 @default.
• W4289525568 cites W1939947548 @default.
• W4289525568 cites W2006990802 @default.
• W4289525568 cites W2038348179 @default.
• W4289525568 cites W2055679739 @default.
• W4289525568 cites W2083355252 @default.
• W4289525568 cites W2143239235 @default.
• W4289525568 cites W2146264128 @default.
• W4289525568 cites W2157166619 @default.
• W4289525568 cites W2160862999 @default.
• W4289525568 cites W2519510391 @default.
• W4289525568 cites W2551817603 @default.
• W4289525568 cites W2604296751 @default.
• W4289525568 cites W2616223277 @default.
• W4289525568 cites W2884536266 @default.
• W4289525568 cites W2899764361 @default.
• W4289525568 cites W2902527999 @default.
• W4289525568 cites W2916296804 @default.
• W4289525568 cites W2963006959 @default.
• W4289525568 cites W2968633786 @default.
• W4289525568 cites W2978646416 @default.
• W4289525568 cites W3006316888 @default.
• W4289525568 cites W3040923122 @default.
• W4289525568 cites W3090822636 @default.
• W4289525568 cites W3093773039 @default.
• W4289525568 cites W3126336573 @default.
• W4289525568 cites W3136078326 @default.
• W4289525568 cites W3153561131 @default.
• W4289525568 cites W3160152094 @default.
• W4289525568 cites W3177134034 @default.
• W4289525568 cites W3206288742 @default.
• W4289525568 cites W3211752197 @default.
• W4289525568 cites W4200439235 @default.
• W4289525568 cites W4200521668 @default.
• W4289525568 cites W4205761485 @default.
• W4289525568 cites W4251646064 @default.
• W4289525568 doi "https://doi.org/10.1016/j.ajpc.2022.100370" @default.
• W4289525568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35968531" @default.
• W4289525568 hasPublicationYear "2022" @default.
• W4289525568 type Work @default.
• W4289525568 citedByCount "4" @default.
• W4289525568 countsByYear W42895255682023 @default.
• W4289525568 crossrefType "journal-article" @default.
• W4289525568 hasAuthorship W4289525568A5010423305 @default.
• W4289525568 hasAuthorship W4289525568A5017974764 @default.
• W4289525568 hasAuthorship W4289525568A5018180754 @default.
• W4289525568 hasAuthorship W4289525568A5032296670 @default.
• W4289525568 hasAuthorship W4289525568A5064308322 @default.
• W4289525568 hasAuthorship W4289525568A5069135092 @default.
• W4289525568 hasAuthorship W4289525568A5088028306 @default.
• W4289525568 hasBestOaLocation W42895255683 @default.
• W4289525568 hasConcept C126322002 @default.
• W4289525568 hasConcept C134018914 @default.
• W4289525568 hasConcept C144024400 @default.
• W4289525568 hasConcept C149923435 @default.
• W4289525568 hasConcept C2426938 @default.
• W4289525568 hasConcept C2777180221 @default.
• W4289525568 hasConcept C2780323712 @default.
• W4289525568 hasConcept C2908647359 @default.
• W4289525568 hasConcept C555293320 @default.
• W4289525568 hasConcept C71924100 @default.
• W4289525568 hasConcept C98274493 @default.
• W4289525568 hasConcept C99454951 @default.
• W4289525568 hasConceptScore W4289525568C126322002 @default.
• W4289525568 hasConceptScore W4289525568C134018914 @default.
• W4289525568 hasConceptScore W4289525568C144024400 @default.
• W4289525568 hasConceptScore W4289525568C149923435 @default.
• W4289525568 hasConceptScore W4289525568C2426938 @default.
• W4289525568 hasConceptScore W4289525568C2777180221 @default.
• W4289525568 hasConceptScore W4289525568C2780323712 @default.
• W4289525568 hasConceptScore W4289525568C2908647359 @default.
• W4289525568 hasConceptScore W4289525568C555293320 @default.
• W4289525568 hasConceptScore W4289525568C71924100 @default.
• W4289525568 hasConceptScore W4289525568C98274493 @default.
• W4289525568 hasConceptScore W4289525568C99454951 @default.
• W4289525568 hasLocation W42895255681 @default.
• W4289525568 hasLocation W42895255682 @default.
• W4289525568 hasLocation W42895255683 @default.
• W4289525568 hasLocation W42895255684 @default.
• W4289525568 hasOpenAccess W4289525568 @default.
• W4289525568 hasPrimaryLocation W42895255681 @default.
• W4289525568 hasRelatedWork W1563850031 @default.
• W4289525568 hasRelatedWork W2033313326 @default.
• W4289525568 hasRelatedWork W2072752555 @default.
• W4289525568 hasRelatedWork W2464808367 @default.
• W4289525568 hasRelatedWork W2745151107 @default.

• next